The clinical challenges of acute on chronic liver failure

@article{Graziadei2011TheCC,
  title={The clinical challenges of acute on chronic liver failure},
  author={Ivo W. Graziadei},
  journal={Liver International},
  year={2011},
  volume={31}
}
Acute on chronic liver failure (ACLF) encompasses patients with previously well‐compensated liver disease in whom an acute decompensation of liver function occurs because of a precipitating event. There are emerging data on the presentation and course of patients with this profile of liver disease; a clear definition based on precise diagnostic criteria, however, remains difficult to establish. In a high percentage of patients, ACLF is associated with the development of multi‐organ failure… Expand
Acute-on-chronic liver failure: recent update
TLDR
It is evident that further refinement of the ACLF classification system is required in order to detect high-risk patients and improve short-term mortality rates, and the use of granulocyte-colony stimulating factor is a promising future therapeutic intervention for patients with ACLF. Expand
Acute-on-chronic liver failure: recent update.
TLDR
It is evident that further refinement of the ACLF classification system is required in order to detect high-risk patients and improve short-term mortality rates, and the use of granulocyte-colony stimulating factor is a promising future therapeutic intervention for patients with ACLF. Expand
Management of Acute on Chronic Liver Failure
TLDR
The pathophysiology of ACLF is not understood completely but many researchers try to explain in a tale with PIRO (predisposition, infection/inflammation, responses, organ failure) concept for sepsis to obtain new treatment method for ACLF with high mortality. Expand
Acute-on-Chronic Liver Failure
TLDR
The “predisposition, infection/inflammation, response, organ failure” (PIRO) concept used to evaluate sepsis may be valuable when it is sought to describe the pathophysiology and clinical features of ACLF. Expand
[Acute-on-chronic liver failure (ACLF)--a new entity in hepatology?].
TLDR
The definition and better understanding of this newly developed and unique profile of liver failure is introduced. Expand
Acute-on-chronic liver failure
TLDR
Although the exact pathogenesis of ACLF remains to be elucidated, alteration of host response to injury, infection, and unregulated inflammation play important roles and the predisposition, infection/inflammation, response, organ failure (PIRO) concept might be useful in describing the pathophysiology and clinical categories for ACLF. Expand
Introduction to Acute Exacerbation of Chronic Hepatitis B (AECHB)
TLDR
This chapter describes definition, natural history and recent achievement debrief of severe hepatitis B, which refers to submassive to massive necrosis in the livers of HBV-infected patients with mild or moderate inflammation, taking place over a short period of time. Expand
Liver transplantation in acute-on-chronic liver failure: lessons learnt from acute liver failure setting
TLDR
Several aspects in transplantation for acute liver failure were found to be relevant to the management of acute-on-chronic liver failure, including defining criteria to identify patients needing early liver transplantation, prioritizing patients with acute liver failures on the waiting list, and the need for a multi-disciplinary approach to manage multiple organ dysfunction. Expand
A novel prognostic score for acute-on-chronic hepatitis B liver failure
  • Zhao Yi, Meng-hou Lu, Xuwen Xu, Xiaoyu Fu, D. Tan
  • Medicine
  • Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
  • 2015
TLDR
In a large cohort of patients retrospectively reviewed for this study, the prognostic model was superior to the MELD score and is, therefore, a promising predictor of short-term survival in patients with HBV-ACLF. Expand
Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study.
TLDR
Intrasplenic hepatocyte transplantation is a promising therapy for liver failure that may reduce mortality rates among patients with end-stage liver disease awaiting OLT and may be considered an alternative to OLT for patients with acute liver failure. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 14 REFERENCES
Acute-on chronic liver failure.
TLDR
This review focuses upon the current understanding of this syndrome from the clinical, prognostic and pathophysiologic perspectives and indicates potential biomarkers and therapeutic targets for intervention. Expand
The pathophysiological basis of acute-on-chronic liver failure.
TLDR
This review focuses upon how a precipitant such as an episode of gastrointestinal bleeding or sepsis may start a cascade of events that culminate in end-organ dysfunction and liver failure. Expand
Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study
TLDR
Patients with ACLF have a high short-term mortality but those who survived the acute exacerbation show a long-term outcome comparable to that of patients with CHD, and early signs of infection, positive systemic inflammatory response syndrome criteria at admission and ductular bilirubinostasis predicted outcome in ACLF. Expand
The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure
TLDR
SIRS is strongly associated with the development of renal dysfunction in patients with non-paracetamol-induced ALF, and it is proposed that the systemic inflammatory cascade plays a key role in its pathogenesis. Expand
Liver transplantation for acute-on-chronic liver failure
TLDR
Liver transplants for acute-on-chronic liver failure is life-saving, and the survival rates it attains are similar to those attained by transplantation for other liver conditions. Expand
Assessment of prognosis of cirrhosis.
TLDR
Along with TIPS, MELD score proved to be a robust marker of early mortality across a wide spectrum of causes of cirrhosis, even though 10 to 20% of patients are still misclassified. Expand
Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival
TLDR
Hydrocortisone administration in these patients is associated with a high frequency of shock resolution and high survival rate, and relative adrenal insufficiency is very frequent in patients with advanced cirrhosis and septic shock. Expand
Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics
TLDR
Cirrhotic patients admitted to intensive care units (ICU) still have poor outcomes, and Liver‐specific scores [Child‐Turcotte‐Pugh (CTP) and model for end‐stage liver disease (MELD)] could be useful in this setting. Expand
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.
TLDR
Primary prophylaxis with norfloxacin has a great impact in the clinical course of patients with advanced cirrhosis, it reduces the incidence of spontaneous bacterial peritonitis, delays the development of hepatorenal syndrome, and improves survival. Expand
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
TLDR
The Asian Pacific Association for the Study of the Liver (APASL) set up a working party on acute-on-chronic liver failure (ACLF) in 2004, with a mandate to develop consensus guidelines on various aspects of ACLF relevant to disease patterns and clinical practice in the Asia-Pacific region, and statements that were unanimously approved by the experts were accepted. Expand
...
1
2
...